Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) plans to
conduct additional clinical trials using DehydraTECH(TM) in CBD after recently
reporting noteworthy results of cardiovascular performance improvements with
TurboCBD. A recent article discussing the company reads, “TurboCBD is Lexaria’s
proprietary DehydraTECH-powered, CBD-fortified hemp-oil capsule. The capsules
are formulated with full-spectrum hemp oil, ginseng and ginkgo for enhanced
focus and memory. They are marketed as a mental and physical boost aimed at
helping to remove brain fog, fatigue and stress. TurboCBD is molecularly
engineered for quick and high absorption rates into the circulatory system. . .
. In a recent press release (http://ibn.fm/OwOtT),
Lexaria announced that the results from a healthy-human clinical trial provided
evidence that a single 90mg dose of TurboCBD resulted in lower blood pressure,
higher blood flow to the brain, faster delivery onset of CBD into the
bloodstream and larger quantities of CBD within the blood as compared to an
equal dose of generic CBD. Due to the positive results of this study, the
company plans to conduct additional human clinical trials over the course of
the next year using DehydraTECH in CBD.”
To view the full article, visit http://ibn.fm/Um7RC
About Lexaria Bioscience Corp.
Lexaria Bioscience has developed and outlicenses its
disruptive delivery technology that promotes healthier ingestion methods, lower
overall dosing and quicker onset of lipophilic active molecules. Lexaria has 10
patents granted in the United States and Australia, and has filed over 50
patent applications worldwide across 10 patent families. Lexaria’s technology
provides more rapid delivery to the bloodstream, as well as important
taste-masking benefits for orally administered bioactive molecules including cannabinoids,
vitamins, nonsteroidal anti-inflammatory drugs (NSAIDs), nicotine and other
molecules. For more information, visit the company’s website at www.LexariaBioscience.com.
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and
more, these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment